Zacks Investment Research
22 Jun 2026, 11:40 UTC · 2h ago
Globus Medical (GMED) Surges 5.1%: Is This an Indication of Further Gains?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
22 Jun 2026, 11:40 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Globus Medical (GMED) reported Q1 2026 adjusted EPS of $1.12 and revenues of $759.9 million, both beating Zacks Consensus Estimates. — Earnings and revenue beats typically trigger positive price action and indicate strong operational health.
+0.60The consensus EPS estimate for Globus Medical (GMED) has been revised 2.5% higher over the last 30 days. — Upward revisions in analyst estimates are strong leading indicators of near-term stock price appreciation.
+0.40Lucid Diagnostics (LUCD) consensus EPS estimate for the upcoming report has increased by 16.7% over the past month to -$0.04. — While still reporting a loss, a significant upward revision in estimates suggests improving fundamentals or narrowing losses.
+0.30Which stocks this story touches
Continue reading
6 related stories
Search tags
Shares rose 5.1% following solid first quarter performance where both earnings and revenue beat estimates.
Shares finished the last trading session 9.9% higher and saw a significant positive revision in EPS estimates.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
58m ago
